Skip to main content
Figure 5 | Annals of Clinical Microbiology and Antimicrobials

Figure 5

From: Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone

Figure 5

Scatter plot comparing tedizolid and linezolid minimum inhibitory concentration (MIC) values for 91 Streptococcus anginosus group isolates. Dashed lines represent the US Food and Drug Administration approved breakpoint for tedizolid for S. anginosus group isolates (≤0.25 μg/ml [susceptible]) and the Clinical and Laboratory Standards Institute approved breakpoint for linezolid (≤2 μg/ml [susceptible]).

Back to article page